NR1H4 and Hepatic fibrosis: GUDCA, a natural antagonist of ileal FXR, could decrease TAA-induced hepatic fibrosis and decrease the protective effects of P. distasonis as revealed by H&E and Masson trichrome staining, and AST and ALT activities (Fig. 3h, i).